Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.450
-0.130 (-5.04%)
At close: Sep 14, 2026, 4:00 PM EDT
2.422
-0.028 (-1.15%)
After-hours: Sep 14, 2026, 6:04 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $17.75 million as of September 14, 2026. Its market cap has increased by 13.16% in one year.
Market Cap
17.75M
Enterprise Value
11.06M
1-Year Change
13.16%
Ranking
Category
Stock Price
$2.45
ChartMarket Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $17.75M, a decrease of -97.19%. That is a compound annual growth rate of -47.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 17.75M | 74.79% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Psyence Biomedical | 20.60M |
| GridAI Technologies | 20.25M |
| Neuphoria Therapeutics | 20.16M |
| Allarity Therapeutics | 19.41M |
| Marker Therapeutics | 19.17M |
| NewcelX | 19.09M |
| Lipocine | 18.71M |
| Pasithea Therapeutics | 17.71M |